Table 4 Comparison of treatment approaches between intestinal BS and mucocutaneous BS
Variables | Intestinal BS (n = 97, %) | Mucocutaneous BS (n = 154, %) |
|---|---|---|
Overall treatment | ||
Intravenous steroid | 97 (100%) | 0 (0.00) |
Oral steroid | 0 (0.00) | 29 (18.83) |
Sulfasalazine | 67 (69.07) | 3 (1.95) |
Mesalazine | 10 (10.31) | 0 (0.00) |
Colchicine | 17 (17.53) | 88 (57.14) |
Thalidomide | 82 (84.54) | 143 (92.86) |
Total glucosides of paeony capsules | 22 (22.68) | 108 (70.13) |
Hydroxychloroquine | 8 (8.25) | 21 (13.64) |
Cyclosporine | 87 (89.69) | 79 (51.30) |
Biologics | 64 (65.98) | 4 (2.60) |
Number of immunosuppressants used | ||
0 | 0 (0) | 2 (1.3) |
1 | 2 (2.1) | 71 (46.1) |
2 | 8 (8.2) | 72 (46.8) |
≥ 3 | 87 (89.7) | 9 (5.8) |